PACTR202303871481191已完成Unknown
carnitine and hemoglobin variability
mohamed sary gharib0 个研究点目标入组 126 人开始时间: 2023年3月5日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 126
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •age greater than 18 years
- •receiving MHD three times per week
排除标准
- •infection, hemoglobin disorders,
- •malignancy,
- •gastrointestinal bleeding,
- •blood transfusions defore study onset
研究者
相似试验
已完成
不适用
The effect of carnitine on patients receiving hemodialysisJPRN-UMIN000007677Apheresis and Dialysis Center, School of medicine, Keio University15
尚未招募
不适用
Impact of L-Carnitine supplementation for hemodialysis patients with heart failure.hemodialysis patients, heart failureJPRN-UMIN000011498Department of Blood purification, Kidney Center, Tokyo Women's Medical University30
已完成
不适用
Supportive effect of carnitine on hepatitis C virus eradication therapyJPRN-UMIN000026079Third department of Internal Medicine, Nara Medical University44
尚未招募
不适用
Blood- and urinary levels of different carnitine-esters during administration of oxaliplatin based chemotherapyCarnitine metabolism and carnitine deficiëncyInteraction of oxaliplatin chemotherapy with carnitineChemotherapy induced peripheral neuropathyNL-OMON21217Máxima Medisch Centrum10
招募中
不适用
Blood- and urinary levels of different carnitine-esters during administration of oxaliplatin based chemotherapyNL-OMON46342Maxima Medisch Centrum10